GRIFOLS BIOSCIENCE R&D SPAIN

The project covers the promoter’s research activities in the fields of plasma-derived therapies, diagnostics and medical solutions for hospitals.

The project covers all stages of development i.e. pre-clinical development as well as clinical development. The project will be managed from the company’s headquarters in Barcelona, Spain.

The project mainly concerns investments in research and development (R&D) that are expected to be carried out in existing facilities already authorised for the same purpose and would therefore not require an environmental impact assessment (EIA) under Directive 2011/92/EU. Full environmental details will be verified during the appraisal.

The promoter is a private company not operating in the Utilities sector and not having the status of a contracting authority. Thus it is not covered by EU directives on procurement. However, the promoter’s procurement procedures are expected to be in line with EIB guidelines for private-sector projects. The Bank’s services will verify details during the project due diligence.